mefloquine ( lariam ) , recently marketed , and if used as 750 mg dose in semi-immune adult patients weighing less than 60 kg , has made possible a single-dose treatment schedule for falciparum malaria .
C0025153
mefloquine
C0024535
falciparum malaria